| 2004 |
AIDA-1 proteins (isoforms AIDA-1a, AIDA-1b, AIDA-1bΔAnk) interact with the amyloid precursor protein (AbetaPP) intracellular domain in vitro, in living cells, and endogenously in leukemia cell lines; overexpression of AbetaPP alters the intracellular distribution of AIDA-1a, and different isoforms localize to distinct subcellular compartments. |
Co-immunoprecipitation, in vitro binding assay, transfection/overexpression with confocal imaging |
Journal of Alzheimer's disease : JAD |
Medium |
15004329
|
| 2005 |
A novel ANKS1B/EB-1 isoform, AIDA-1c, interacts with the Cajal body marker protein coilin and competes with SmB' for coilin binding sites but does not bind SMN; knockdown of EB-1/AIDA-1 isoforms by siRNA alters Cajal body organization and reduces cell viability. |
Co-immunoprecipitation, competition binding assay, siRNA knockdown, fluorescence microscopy |
BMC cell biology |
Medium |
15862129
|
| 2007 |
AIDA-1d is a postsynaptic density component that binds the first two PDZ domains of PSD-95 via its C-terminal three amino acids; NMDA receptor stimulation induces Ca2+-independent translocation of AIDA-1d to the nucleus where it couples to Cajal bodies and induces Cajal body-nucleolar association, leading to increased nucleolar numbers and protein synthesis. |
Co-immunoprecipitation, live-cell imaging, NMDA stimulation, siRNA knockdown with protein synthesis assay |
Nature neuroscience |
High |
17334360
|
| 2009 |
NMR structure of the tandem SAM domain of AIDA-1 reveals a head-to-tail orientation with the nuclear localization signal buried at the SAM-SAM domain interface; differential thermal stability of the two SAM domains suggests a mechanism whereby the second SAM domain decouples from the first to expose the NLS and facilitate nuclear import. |
NMR structure determination, thermal stability assay |
Journal of molecular biology |
High |
19666031
|
| 2015 |
AIDA-1 preferentially associates with GluN2B and with CASK and KIF17 (adaptors regulating GluN2B-containing NMDAR transport from ER to synapses); conditional forebrain knockout of AIDA-1 reduces GluN2B-mediated and increases GluN2A-mediated synaptic transmission, with GluN2B accumulating in ER-enriched fractions, indicating AIDA-1 facilitates ER-to-synapse transport of GluN2B. |
Conditional knockout, co-immunoprecipitation, subcellular fractionation, electrophysiology, lentiviral shRNA knockdown, immunocytochemistry |
The Journal of neuroscience |
High |
26085624
|
| 2015 |
Under basal conditions, AIDA-1 is located within the dense core of the PSD (~30 nm from postsynaptic membrane); under excitatory conditions (high K+ or NMDA), AIDA-1 label density at the PSD core is reduced to 40% of controls and median distance increases to ~55 nm, with the effect reversible within 30 minutes. |
Immunogold electron microscopy with two distinct antibodies in cultured hippocampal neurons |
PloS one |
Medium |
26356309
|
| 2015 |
ANKS1B was identified as a novel binding partner of KRIT1 (CCM1) by yeast two-hybrid screen; silencing of ANKS1B in primary human endothelial cells increases permeability, and forced ANKS1B expression reduces permeability, independently of Rho kinase activity and KRIT1 presence. |
Yeast two-hybrid screen, siRNA knockdown, overexpression, endothelial permeability assay |
PloS one |
Medium |
26698571
|
| 2016 |
CaMKII activation phosphorylates AIDA-1 in PSD fractions from brain, and NMDA treatment causes an ~30 nm shift in AIDA-1 median distance from the postsynaptic membrane in hippocampal neurons; this redistribution is blocked by the CaMKII inhibitor tatCN21, establishing CaMKII-mediated phosphorylation as the mechanism for activity-induced displacement of AIDA-1 from the PSD core. |
Biochemical phosphorylation assay of PSD fractions, immuno-electron microscopy, CaMKII inhibitor treatment |
FEBS letters |
High |
27477489
|
| 2019 |
Quantitative proteomics of the AIDA-1 interactome in neurons identifies protein networks involved in synaptic function; haploinsufficiency of ANKS1B in a transgenic mouse model recapitulates social deficits, hyperactivity, and sensorimotor dysfunction, demonstrating AIDA-1 loss-of-function drives specific neurodevelopmental phenotypes. |
Quantitative mass spectrometry-based proteomics (interactome), transgenic mouse model with behavioral analysis |
Nature communications |
High |
31388001
|
| 2023 |
Anks1b-deficient mice display deficits in oligodendrocyte maturation, myelination, and Rac1 function; selective loss of Anks1b from the oligodendrocyte lineage (but not from neurons) recapitulates social preference and sensory reactivity deficits, and clemastine rescues social deficits in these mice, establishing an oligodendroglial role for AIDA-1 mediated by Rac1 activity. |
Conditional cell-type-specific knockout, MRI white matter imaging, oligodendrocyte maturation assays, Rac1 activity assay, pharmacological rescue |
Nature communications |
High |
38129387
|
| 2024 |
The PTB domain of AIDA-1 binds to an extended NPx[F/Y]-motif of SynGAP family Ras-GTPase activating proteins with high affinity; crystal structure of the AIDA-1 PTB domain in complex with the SynGAP NPxF-motif reveals the molecular basis for this specific interaction. |
Affinity purification, biochemical binding assay, X-ray crystallography |
Journal of molecular biology |
High |
38759928
|
| 2026 |
Ischemia induces lactylation of ANKS1B at K1222, targeting it for ubiquitin-proteasome-mediated degradation; loss of ANKS1B causes GluN2B retention in the ER, while a lactylation-resistant mutant (K1222R) restores GluN2B surface trafficking but exacerbates Ca2+ overload and neuronal death, indicating lactylation-driven ANKS1B degradation is a neuroprotective feedback mechanism limiting excitotoxicity. |
Proteomics, OGD/R cell model, ubiquitin-proteasome pathway assay, site-directed mutagenesis (K1222R), Ca2+ imaging, surface trafficking assay |
Biochemical and biophysical research communications |
Medium |
41564684
|